Investor Relations

Press, quotes, SEC filings, alerts, more.

COVID-19

Launching ARTIVeda™ for COVID-19 in India.

Pipeline

Cancer and viral infection treatment information.

EdgePoint AI

Core cloud-computer AI platform.

Most recent news and events

Oncotelic Happenings

Dr. Vuong Trieu presented at the 7th JCA-AACR Special Joint Conference (July 8-10, 2022) Learn more >

Dr. Vuong Trieu presented at the BIO International Convention, San Diego (June 13-16, 2022) Learn more >

AACR Annual Meeting 2022. April 8 – 13, 2022, New Orleans, Louisiana. Learn more >

Dr. Vuong Trieu presented at the MedInvest Pharmaceutical & Biotechnology Investor Conference (March 30-31, 2022) Learn more >

Biotechgate Digital Partnering February 2022 (7 – 11 Feb, 2022) Learn more >

2nd Annual TGF-β for Immuno-Oncology Drug Development Summit (tgf-beta-summit.com) (January 25, 2022 to January 27, 2022) Learn more >

Oncotelic Therapeutics Investor Presentation 10-26-2021. Learn more >

11 Billion $

target markets

100 Plus

patent applications

2 Key

clinical programs

30 Years

experience

Questions or Comments?

Copyright © 2020 Oncotelic Inc., a TGF ImmunoOncology Company. All rights reserved.